首页> 外文期刊>Journal of Pathology: Journal of the Pathological Society of Great Britain and Ireland >Transplanted hepatocytes engraft, survive, and proliferate in the liver of rats with carbon tetrachloride-induced cirrhosis.
【24h】

Transplanted hepatocytes engraft, survive, and proliferate in the liver of rats with carbon tetrachloride-induced cirrhosis.

机译:移植的肝细胞在四氯化碳诱导的肝硬化大鼠的肝脏中移植,存活和增殖。

获取原文
获取原文并翻译 | 示例
           

摘要

Repopulation of the cirrhotic liver with disease-resistant hepatocytes could offer novel therapies, as well as systems for biological studies. Establishing whether transplanted hepatocytes can engraft, survive, and proliferate in the cirrhotic liver is a critical demonstration. Dipeptidyl peptidase IV-deficient F344 rats were used to localize transplanted hepatocytes isolated from the liver of syngeneic normal F344 rats. Cirrhosis was induced by administration of carbon tetrachloride with phenobarbitone and these drugs were withdrawn prior to cell transplantation. Cirrhotic rats showed characteristic hepatic histology, as well as significant portosystemic shunting. When hepatocytes were transplanted via the spleen, cells were distributed immediately in periportal areas, fibrous septa, and regenerative nodules of the cirrhotic liver. Although some transplanted cells translocated into pulmonary capillaries, this was not deleterious. At 1 week, transplanted cells were fully integrated in the liver parenchyma, along with expression of glucose-6-phosphatase and glycogen as reporters of hepatic function. Transplanted cells proliferated in the liver of cirrhotic animals and survived indefinitely. At 1 year, transplanted hepatocytes formed large clusters containing several-fold more cells than normal control animals, which was in agreement with increased cell turnover in the cirrhotic rat liver. The findings indicate that the cirrhotic liver can be repopulated with functionally intact hepatocytes that are capable of proliferating. Liver repopulation using disease-resistant hepatocytes will be applicable in chronic conditions, such as viral hepatitis or Wilson's disease. Copyright 2000 John Wiley & Sons, Ltd.
机译:用抗病性肝细胞填充肝硬化肝脏可以提供新的疗法以及生物学研究系统。一个关键的证明是确定移植的肝细胞是否可以在肝硬化肝中移植,存活和增殖。缺乏二肽基肽酶IV的F344大鼠用于定位从同基因正常F344大鼠的肝脏分离的移植肝细胞。通过与苯巴比妥合用四氯化碳诱发肝硬化,在细胞移植前将这些药物撤出。肝硬化大鼠表现出特征性肝组织学,以及明显的门体分流。当通过脾脏移植肝细胞时,细胞立即分布在肝硬化肝的门周围区域,纤维间隔和再生结节中。尽管一些移植的细胞易位进入肺毛细血管,但这并不是有害的。在第1周,移植的细胞与肝功能的报告基因葡萄糖-6-磷酸酶和糖原的表达完全融合在肝实质中。移植的细胞在肝硬化动物的肝脏中增殖,并无限期存活。在1年时,移植的肝细胞形成了较大的簇,包含的细胞比正常对照动物多了几倍,这与肝硬化大鼠肝脏中细胞更新的增加一致。这些发现表明,肝硬化肝脏可以用功能完整的肝细胞增殖,这些肝细胞能够增殖。使用抗病性肝细胞进行的肝脏再填充将适用于慢性病,例如病毒性肝炎或威尔逊氏病。版权所有2000 John Wiley&Sons,Ltd.

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号